BOLD
Price
$1.15
Change
-$0.01 (-0.86%)
Updated
Dec 11 closing price
Capitalization
25.74M
Intraday BUY SELL Signals
CTNM
Price
$13.07
Change
+$0.55 (+4.39%)
Updated
Dec 11 closing price
Capitalization
381.42M
83 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BOLD vs CTNM

Header iconBOLD vs CTNM Comparison
Open Charts BOLD vs CTNMBanner chart's image
Boundless Bio
Price$1.15
Change-$0.01 (-0.86%)
Volume$72.37K
Capitalization25.74M
Contineum Therapeutics
Price$13.07
Change+$0.55 (+4.39%)
Volume$79.86K
Capitalization381.42M
BOLD vs CTNM Comparison Chart in %
BOLD
Daily Signal:
Gain/Loss:
CTNM
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BOLD vs. CTNM commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLD is a Hold and CTNM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (BOLD: $1.15 vs. CTNM: $13.07)
Brand notoriety: BOLD and CTNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLD: 43% vs. CTNM: 58%
Market capitalization -- BOLD: $25.74M vs. CTNM: $381.42M
BOLD [@Biotechnology] is valued at $25.74M. CTNM’s [@Biotechnology] market capitalization is $381.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLD’s FA Score shows that 1 FA rating(s) are green whileCTNM’s FA Score has 1 green FA rating(s).

  • BOLD’s FA Score: 1 green, 4 red.
  • CTNM’s FA Score: 1 green, 4 red.
According to our system of comparison, CTNM is a better buy in the long-term than BOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLD’s TA Score shows that 4 TA indicator(s) are bullish while CTNM’s TA Score has 5 bullish TA indicator(s).

  • BOLD’s TA Score: 4 bullish, 5 bearish.
  • CTNM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CTNM is a better buy in the short-term than BOLD.

Price Growth

BOLD (@Biotechnology) experienced а +4.55% price change this week, while CTNM (@Biotechnology) price change was +19.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

CTNM is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTNM($381M) has a higher market cap than BOLD($25.7M). CTNM has higher P/E ratio than BOLD: CTNM (26.40) vs BOLD (0.16). CTNM YTD gains are higher at: -10.785 vs. BOLD (-60.345). CTNM has higher annual earnings (EBITDA): -57.1M vs. BOLD (-70.2M). CTNM has more cash in the bank: 175M vs. BOLD (127M). CTNM has less debt than BOLD: CTNM (5.75M) vs BOLD (49.5M). BOLD (0) and CTNM (0) have equivalent revenues.
BOLDCTNMBOLD / CTNM
Capitalization25.7M381M7%
EBITDA-70.2M-57.1M123%
Gain YTD-60.345-10.785560%
P/E Ratio0.1626.401%
Revenue00-
Total Cash127M175M73%
Total Debt49.5M5.75M861%
TECHNICAL ANALYSIS
Technical Analysis
BOLDCTNM
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
73%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 23 days ago
90%
Bearish Trend 19 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 8 days ago
90%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BOLD
Daily Signal:
Gain/Loss:
CTNM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMNM1.990.24
+13.71%
Bimini Capital Management, Inc.
JRNGF2.540.01
+0.28%
Journey Energy Inc.
SIEVF191.00N/A
N/A
D IETEREN GROUP NV
MONSF71.23N/A
N/A
MONTEA SICAFI
SFTBF108.06-9.69
-8.23%
Softbank Group Corp

BOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with RCKT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
-0.86%
RCKT - BOLD
40%
Loosely correlated
-4.96%
RGNX - BOLD
37%
Loosely correlated
-1.61%
ZNTL - BOLD
36%
Loosely correlated
+2.11%
DSGN - BOLD
35%
Loosely correlated
-1.91%
DNLI - BOLD
35%
Loosely correlated
-1.14%
More

CTNM and

Correlation & Price change

A.I.dvisor tells us that CTNM and CCCC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTNM and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
+4.39%
CCCC - CTNM
29%
Poorly correlated
-1.55%
VYGR - CTNM
29%
Poorly correlated
-0.23%
TNGX - CTNM
28%
Poorly correlated
-0.76%
MREO - CTNM
27%
Poorly correlated
-2.60%
SLN - CTNM
27%
Poorly correlated
+2.88%
More